| Ref No | Member | Question | Tabled | Status |
|
AQW 54142/22-27
|
Mr Stephen Dunne
(DUP - North Down)
|
To ask the Minister of Health (i) whether a target timescale exists for undertaking an MRI scan, following identification of a suspected brain tumour on CT imaging; (ii) to detail the average waiting time for such MRI scans, in each of the last five years; and (iii) whether his Department has made any assessment on whether the current arrangements are sufficient, to ensure patients receive timely diagnosis and treatment.
| 08/10/2026 |
To be answered by 23/10/2026
|
|
AQW 54141/22-27
|
Mr Stephen Dunne
(DUP - North Down)
|
To ask the Minister of Health to detail (i) any assessment that has been made of delays in routine surveillance MRI scans for brain tumour patients, following completion of treatment; (ii) the number of patients awaiting a scheduled three-month or six-month follow-up MRI scan who did not receive a scan within the planned timeframe, in each of the last five years; and (iii) any measures that are being taken to reduce such delays.
| 08/10/2026 |
To be answered by 23/10/2026
|
|
AQW 54140/22-27
|
Mr Stephen Dunne
(DUP - North Down)
|
To ask the Minister of Health to detail (i) any assessment that has been made of the emerging evidence relating to CAR T-cell therapy, in patients with high-grade gliomas and other malignant brain tumours; (ii) the reason why patients in Northern Ireland cannot currently access CAR T-cell therapy for brain cancer through the NHS; and (iii) any steps that are being taken to facilitate participation in CAR T-cell clinical trials for eligible patients.
| 08/10/2026 |
To be answered by 23/10/2026
|
|
AQW 54139/22-27
|
Mr Stephen Dunne
(DUP - North Down)
|
To ask the Minister of Health to detail (i) the number of patients that were diagnosed with (a) Grade 3; and (b) Grade 4 gliomas, in each of the last five years; (ii) the (a) one-year; (b) three-year; and (c) five-year, survival rates; and (iii) any actions that are being taken to improve outcomes for these patients.
| 08/10/2026 |
To be answered by 23/10/2026
|
|
AQW 54138/22-27
|
Mr Stephen Dunne
(DUP - North Down)
|
To ask the Minister of Health to detail (i) any assessment that has been made of barriers preventing brain tumour patients in Northern Ireland from accessing emerging treatments; (ii) whether a review of any barriers has been undertaken, within the last five years; and (iii) any actions that have been identified to address any barriers.
| 08/10/2026 |
To be answered by 23/10/2026
|
|
AQW 53894/22-27
|
Mr Stephen Dunne
(DUP - North Down)
|
To ask the Minister of Health to detail (i) the number of consultant neuro-oncology posts, including the number that are vacant; and (ii) any steps being taken to ensure sufficient specialist capacity to support brain tumour patients.
| 06/10/2026 |
To be answered by 21/10/2026
|
|
AQW 53893/22-27
|
Mr Stephen Dunne
(DUP - North Down)
|
To ask the Minister of Health whether (i) the Cancer Research Strategic Framework contains any actions specifically targeted at improving outcomes for patients with brain tumours; and (ii) any consideration will be given to developing a dedicated brain tumour research programme.
| 06/10/2026 |
To be answered by 21/10/2026
|
|
AQW 53892/22-27
|
Mr Stephen Dunne
(DUP - North Down)
|
To ask the Minister of Health to detail whether any (i) assessment has been made of GP awareness and training in relation to the signs and symptoms of brain tumours; (ii) consideration has been given to issuing additional guidance or training to GPs; and (iii) steps are being taken to improve referral pathways for patients presenting with symptoms consistent with a brain tumour.
| 06/10/2026 |
To be answered by 21/10/2026
|
|
AQW 53891/22-27
|
Mr Stephen Dunne
(DUP - North Down)
|
To ask the Minister of Health (i) whether any assessment has been made of the reasons as to why a significant proportion of brain tumours are diagnosed through emergency presentation rather than established referral pathways; (ii) to detail any steps that are being taken to improve earlier diagnosis; and (iii) whether any targets have been set to reduce emergency presentations.
| 06/10/2026 |
To be answered by 21/10/2026
|
|
AQW 53890/22-27
|
Mr Stephen Dunne
(DUP - North Down)
|
To ask the Minister of Health to detail (i) any mechanisms in place to support investigator-led clinical trials of off-patent medicines for patients with life-limiting conditions, including brain tumours; (ii) any dedicated funding that is available for such studies; and (iii) whether any assessment has been made of whether the current system adequately supports research into low-cost repurposed medicines where there is no commercial sponsor.
| 06/10/2026 |
To be answered by 21/10/2026
|
|